Obesity and non-alcoholic fatty liver disease (NAFLD) have been associated with an increase in IL-17A, which is produced in the intestinal mucosa, and its levels are modulated by microbiome composition [29,30]. Here, IL17A is linked to obesity due to melanocortin 4 receptor deficiency.